Open wounds involving multiple body regions

ST19_OPEN_WOUNDS_INVOLVI_MULTIPLE_BODY_REGIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T01 Cause of death: ICD-10 — T01 2 out of 7 registries used, show all original rules.	147
4. Check minimum number of events None	147
5. Include endpoints None	147
6. Filter based on genotype QC (FinnGen only)	140

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T0[0-7]
Name in latin: Vulnera regionum multarum corporis

NAME	ST19_OPEN_WOUNDS_INVOLVI_MULTIPLE_BODY_REGIONS
CONTROL_EXCLUDE	ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Open wounds involving multiple body regions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	140	71	69
Unadjusted period prevalence (%)	0.03	0.03	0.03
Median age at first event (years)	47.07	47.50	46.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
147: Matched controls
1470

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T01.9

ICD-10 Finland

Multiple open wounds, unspecified

+∞

64.4

T01.8

ICD-10 Finland

Open wounds involving other combinations of body regions

+∞

33.6

T01.0

ICD-10 Finland

Open wounds involving head with neck

+∞

25.8

T01.2

ICD-10 Finland

Open wounds involving multiple regions of upper limb(s)

+∞

17.0

T01.3

ICD-10 Finland

Open wounds involving multiple regions of lower limb(s)

+∞

13.8

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.4

10.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

9.6

10.5

X78

ICD-10 Finland

Intentional self-harm by sharp object

35.5

8.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

10.3

8.0

W55

ICD-10 Finland

Bitten or struck by other mammals

7.9

7.7

B18.2

ICD-10 Finland

Chronic viral hepatitis C

14.7

7.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

6.9

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

72.9

6.5

T01.1

ICD-10 Finland

Open wounds involving thorax with abdomen, lower back and pelvis

+∞

6.3

T01.6

ICD-10 Finland

Open wounds involving multiple regions of upper limb(s) with lower limb(s)

+∞

6.3

S97

ICPC

Chronic ulcer skin

4.4

6.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.8

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000991) Gas panel - Venous blood

3.93

8.59

14.2

8.3

—

(3023368) Bacteria identified in Blood by Culture

281

2.60

6.93

6.0

4.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

131

2.73

5.26

2.7

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.54

4.62

1.9

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.47

4.48

1.8

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

152

2.41

4.24

2.3

1.9

—

(3002032) Base excess in Venous blood by calculation

2.70

4.23

3.3

3.6

1.54

1.99

mmol/l

0.19

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

110

2.53

3.88

2.4

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

113

2.46

3.67

2.4

1.8

—

(3016879) Cocaine [Presence] in Urine

2.92

3.63

2.6

1.4

—

(3036180) Methadone [Presence] in Urine

8.10

3.60

1.6

1.1

—

(40758558) Short blood count panel - Blood

280

2.00

3.52

4.8

7.1

—

(3030467) Casts [#/volume] in Urine by Automated count

310

1.93

3.31

3.1

2.4

0.35

0.26

e6/l

0.31

242

(36304419) Bacteria [Presence] in Urine

302

1.93

3.30

3.1

2.4

—

(3000764) Benzodiazepines [Presence] in Urine

2.74

3.26

2.6

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.63

3.19

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

2.70

3.17

2.6

1.4

—

(3027008) Opiates [Presence] in Urine

2.70

3.17

2.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

2.70

3.17

2.6

1.4

—

(3018095) Leukocytes [#/volume] in Urine

393

1.84

3.10

3.4

99.49

58.01

e6/l

0.36

290

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

7.76

3.08

2.8

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

3.75

3.06

2.2

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

204

2.01

3.06

1.5

1.7

—

(3003396) Base excess in Arterial blood by calculation

117

2.26

2.98

17.8

12.9

0.23

1.38

mmol/l

0.69

(3052851) Hemolysis interference index of Serum or Plasma

4.29

2.93

2.8

3.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

408

1.80

2.91

2.2

1.9

89.09

97.36

pmol/l

0.89

208

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.94

2.90

2.2

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.76

2.79

18.4

19.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

211

1.94

2.77

4.4

3.6

31.94

62.28

ng/l

0.58

156

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

252

1.87

2.73

2.1

1.8

0.95

1.28

mg/l

0.48

205

(3002582) Erythrocytes [#/volume] in Urine

336

1.79

2.72

3.0

2.8

11.88

56.65

e6/l

2.20

270

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.97

2.50

1.1

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.96

2.40

1.1

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

100

2.16

2.34

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

4.03

2.28

2.3

2.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

378

1.68

2.27

4.1

2.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.82

2.11

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

716

1.62

2.09

5.7

4.1

—

3285.29

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

441

1.61

2.04

2.1

2.3

72.16

74.65

nmol/l

0.30

398

(46235355) HIV 1 and 2 tests - Meaningful Use set

260

1.68

1.93

1.8

2.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.32

1.90

2.6

2.3

0.70

0.69

0.03

(3025941) Bacteria identified in Stool by Culture

2.12

1.88

1.3

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.38

1.86

12.5

6.3

24.07

25.06

mmol/l

0.21

(4094501) Cardiovascular stress test using bicycle ergometer

2.86

1.82

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

165

1.78

1.81

1.5

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

183

1.73

1.74

2.6

2.4

0.43

1.08

e6/l

1.52

112

(3042936) Bacteria identified in Isolate by Culture

143

1.81

1.74

3.9

2.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

483

1.53

1.73

9.7

11.4

1.16

1.18

inr

0.10

159

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.20

1.71

2.8

2.3

1.84

1.27

0.79

(3036489) Thrombin time

2.48

1.65

2.2

2.0

21.70

23.16

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

662

1.50

1.61

13.2

9.9

4.48

4.13

e9/l

0.73

602

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

171

1.71

1.60

2.5

3.00

2.72

e6/l

0.04

101

(3026008) Bacteria identified in Urine by Culture

299

1.57

1.59

4.0

2.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2.67

1.53

3.0

2.5

3.37

3.20

g/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.93

1.52

6.5

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

182

1.67

1.52

2.7

2.1

1.67

1.42

0.93

167

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.52

1.51

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.52

1.51

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

458

1.48

11.4

7.4

1.19

1.21

mmol/l

1.16

421

(3000850) Epithelial cells [#/volume] in Urine

243

1.58

1.46

2.7

2.1

6.17

4.41

e6/l

0.53

220

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

245

1.56

1.41

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

343

1.50

1.40

2.3

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.67

1.38

2.5

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

353

1.49

1.38

2.4

3.4

2.35

2.34

mmol/l

0.38

315

(3013115) Eosinophils [#/volume] in Blood

582

1.43

1.30

10.5

6.3

0.16

0.19

e9/l

0.91

535

(4200892) Spirometry reversibility

1.88

1.26

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.46

1.25

1.5

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

1.17

0.0

4.8

—

25.15

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

504

1.40

1.16

11.1

8.4

1.19

1.21

mmol/l

1.27

428

(3021589) Normoblasts [#/volume] in Blood

504

1.40

1.16

12.6

9.4

0.00

e9/l

0.80

421

(3001604) Monocytes [#/volume] in Blood

562

1.39

1.16

10.1

6.1

0.56

0.57

e9/l

0.14

511

(3006315) Basophils [#/volume] in Blood

562

1.39

1.16

10.2

6.1

0.04

e9/l

0.44

513

(3020891) Body temperature

2.06

1.14

9.6

4.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.10

1.2

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.10

1.2

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

537

1.38

1.10

8.8

6.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

128

1188

1.60

1.09

23.5

13.2

25.38

20.60

mg/l

0.96

109

915

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.18

1.07

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.18

1.07

3.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

278

1.44

1.07

3.2

3.4

3381.22

1030.64

ng/l

0.57

229

(3011397) Hemoglobin [Presence] in Urine by Test strip

243

1.46

1.05

6.7

3.5

—

(3019198) Lymphocytes [#/volume] in Blood

579

1.36

1.04

10.5

6.1

1.97

1.90

e9/l

0.19

537

(1761868) Lipid panel - Serum or Plasma

486

0.71

1.04

2.1

2.7

—

(3018418) pH of Serum or Plasma

318

1.40

0.99

3.8

4.2

7.39

7.41

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.99

0.98

2.7

2.0

95.14

92.08

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

180

0.58

0.94

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

120

1110

1.44

0.92

4.5

4.3

6.17

5.85

mmol/l

1.17

114

1023

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

520

1.33

0.92

2.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

879

1.34

0.90

9.4

7.5

80.08

76.33

u/l

0.45

817

(3003694) ABO and Rh group [Type] in Blood

342

1.36

0.89

1.5

1.4

—

(3026782) Osmolality of Urine

234

1.41

0.87

2.6

2.5

485.52

550.23

mosm/kgh2o

0.77

198

(3011288) Drugs identified in Urine by Screen method

1.82

0.86

4.6

1.7

—

(3037121) Protein [Mass/volume] in Urine

1.97

0.85

2.0

3.6

—

0.25

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

114

1.56

0.84

3.6

4.4

32.67

30.63

0.31

(3023103) Potassium [Moles/volume] in Serum or Plasma

126

1182

1.46

0.83

27.3

15.1

4.00

3.96

mmol/l

0.66

121

1143

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

115

1.54

0.81

5.6

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

867

1.31

0.79

4.2

3.9

14.75

14.64

pmol/l

0.17

796

(3020682) Albumin/Creatinine [Ratio] in Urine

321

1.34

0.78

3.4

3.7

22.87

12.93

mg/mmol

0.34

208

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

118

1099

1.37

0.77

19.7

12.1

89.19

85.32

ml/min/173m2

0.95

882

(3022313) Gas panel - Capillary blood

1.80

0.77

1.8

3.1

—

(3000492) Spirometry study

125

1.50

0.77

2.0

1.4

—

(3019150) Specific gravity of Urine by Refractometry

258

1.36

0.76

7.4

3.8

1.02

kg/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.03

0.73

1.0

1.3

—

(40768797) Stomach Pathology biopsy report

145

1.44

0.70

1.2

1.3

—

(21494755) Public health laboratory ask at order entry panel

154

0.62

0.69

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

837

1.27

0.66

3.3

3.1

—

(3012516) Albumin [Mass/volume] in Urine

301

1.31

0.66

2.9

3.2

77.64

503.72

mg/l

0.84

199

(3037467) Urinalysis macro (dipstick) panel - Urine

767

1.26

0.65

4.2

4.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

302

1.30

0.64

2.2

2.6

325.37

5911.94

umol/l

1.34

259

(3034770) Mitochondria Ab [Titer] in Serum

1.75

0.64

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.75

0.64

1.6

2.1

—

(40761535) Cells panel - Urine sediment

1.59

0.64

7.7

3.2

—

(1002224) Polysomnography panel

1.63

0.63

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.69

0.62

3.2

2.5

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.61

0.0

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.61

0.0

1.1

—

1.30

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.61

0.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

171

0.68

0.59

2.8

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.48

0.54

1.2

1.6

1.09

1.02

g/l

—

(3013512) EKG study

300

1.26

0.54

3.5

3.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

188

0.72

0.51

2.9

2.3

—

(3044889) 12 lead EKG panel

809

0.83

0.50

4.8

3.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

121

1.36

0.46

16.3

7.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

344

0.80

0.44

3.2

—

(3009508) Creatinine [Moles/volume] in Urine

346

1.21

0.43

3.2

3.0

5.95

7.94

mmol/l

2.27

298

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.58

0.42

1.4

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.41

0.0

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.41

0.0

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.42

0.38

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

153

1.28

0.37

2.1

2.2

2.62

2.39

g/l

1.02

140

(3019060) Gas panel - Arterial blood

1.28

0.37

9.2

11.7

—

(40768443) Skin Pathology biopsy report

1.45

0.36

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

133

0.73

0.35

1.7

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

110

1.30

0.33

1.2

4.0

2.31

1.72

0.79

102

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

122

1179

1.20

0.32

4.5

4.7

2.67

2.80

mmol/l

0.89

112

1098

(3013707) Erythrocyte sedimentation rate by Westergren method

862

1.15

0.30

4.9

3.9

13.47

10.58

mm/h

0.94

793

(3035350) Ketones [Presence] in Urine by Test strip

563

1.14

0.30

5.3

3.6

0.00

estimate

—

112

(3029937) Albumin [Presence] in Urine by Test strip

309

0.85

0.29

7.3

3.7

0.00

estimate

—

106

(3019225) pH of Specimen

1.32

0.29

3.6

5.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

119

0.74

0.28

1.1

2.0

321.44

412.75

nmol/l

—

111

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

428

1.14

0.28

4.7

3.6

21.01

46.01

ng/l

1.09

268

(3002256) Pathology report gross observation

125

1.22

0.23

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.76

0.23

2.3

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

563

1.11

0.21

7.1

5.0

0.00

estimate

—

107

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

5.63

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.21

0.0

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.52

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

3.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

3.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

24.32

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.00

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(40768804) Tissue Pathology biopsy report

426

1.12

0.21

1.8

—

(40768800) Prostate Pathology biopsy report

0.00

0.21

0.0

1.3

—

(3008295) Osmolality of Serum or Plasma

0.00

0.21

0.0

1.2

—

275.38

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

290

0.87

0.20

1.3

1.2

0.50

0.99

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

242

1.14

0.20

1.6

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

110

1068

1.12

0.19

5.2

4.5

1.77

1.86

mu/l

0.42

103

983

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

131

0.83

0.18

1.3

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.76

0.17

2.2

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.72

0.17

1.0

1.8

—

(3022145) Colonoscopy Study observation

120

1.18

0.17

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

120

1.18

0.17

1.9

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

198

1.13

0.15

1.2

1.3

11.08

28.73

iu/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.12

0.15

2.1

1.9

11.99

10.78

g/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.83

0.14

1.1

1.4

—

(40761536) Microorganisms panel - Urine sediment

0.80

0.14

4.0

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

455

0.92

0.13

6.5

3.7

—

(3009261) Glucose [Presence] in Urine by Test strip

575

1.07

0.12

5.4

3.6

0.00

estimate

—

102

(3003327) Ova and parasites identified in Stool by Light microscopy

1.11

0.10

1.2

1.5

—

(4035726) Immunohistochemistry procedure

1.16

0.09

1.6

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.09

0.09

3.0

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

277

0.93

0.09

3.2

3.8

22.12

22.10

—

102

(3008898) HLA-B27 [Presence]

1.04

0.08

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.03

0.08

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

102

0.87

0.06

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

139

1.09

0.05

2.0

1.5

—

(40761511) CBC panel - Blood by Automated count

125

1238

1.06

0.05

19.0

12.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

108

1067

1.05

0.05

6.2

5.3

41.06

39.51

mmol/mol

0.68

1008

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

128

1269

1.07

0.05

13.2

10.0

31.98

27.50

u/l

1.31

123

1222

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

113

1119

1.04

0.04

3.7

3.9

1.26

1.32

mmol/l

0.39

103

1038

(3007164) IgA [Mass/volume] in Serum or Plasma

261

1.04

0.03

1.2

1.3

3.63

2.37

g/l

0.79

165

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

208

0.96

0.02

2.6

0.74

0.76

ug/l

0.03

115

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

116

1168

0.97

0.02

4.3

4.51

4.69

mmol/l

1.26

109

1093

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

146

0.95

0.00

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

116

1159

1.00

0.00

4.2

1.39

1.45

mmol/l

0.93

108

1078

(3009542) Hematocrit [Volume Fraction] of Blood

132

1322

0.99

0.00

36.2

19.2

38.61

40.87

2.49

125

1245

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

195

1.03

0.00

1.2

1.3

34.01

9.18

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

14.60

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.97

-0.00

4.7

4.0

1.21

1.23

mmol/l

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

1.12

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

238.00

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.2

—

1.19

—

(3000330) Specific gravity of Urine by Test strip

0.86

-0.00

2.4

4.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.91

-0.00

1.5

2.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

-0.00

0.0

2.4

—

5.09

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

2.3

—

13.44

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

9.49

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.98

-0.00

3.0

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

3.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

0.00

-0.00

0.0

1.3

—

47.29

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

27.60

—

(44813793) Dust mix specific IgE antibody measurement

0.00

-0.00

0.0

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.93

-0.00

2.3

2.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

5.48

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

2.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.8

—

7.23

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

453.17

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

1.7

—

64.58

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

56.50

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

42.10

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OPEN_WOUNDS_INVOLVI_MULTIPLE_BODY_REGIONS – Open wounds involving multiple body regions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Open wounds involving multiple body regions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Open wounds involving multiple body regions (ST19_OPEN_WOUNDS_INVOLVI_MULTIPLE_BODY_REGIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints